Latest Breaking News On - Patients with aggressive lymphomas - Page 1 : comparemela.com

Jeremy L. Ramdial, MD, discusses the myeloablative conditioning regimen gemcitabine, clofarabine, and busulfan in patients with aggressive lymphomas.

United statesJeremyl ramdialUniversity of texas md anderson cancer centerDivision of cancer medicineDepartment of stem cell transplantationStem cell transplantationCellular therapyCancer medicineCancer centerThe university of texas md anderson cancer centerLofarabine and busulfanPatients with aggressive lymphomas